Welcome to our dedicated page for RingCentral SEC filings (Ticker: RNG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RingCentral鈥檚 growth story lives inside its SEC filings. From recurring subscription revenue to service level guarantees on its cloud communications platform, each document outlines the mechanics of a business that replaces legacy phone systems with voice, video, and messaging in the cloud.
Want to know where executives buy or sell shares? The RingCentral insider trading Form 4 transactions feed surfaces every move, while our alert system tracks RingCentral Form 4 insider transactions real-time. Curious about churn trends or average revenue per user? The RingCentral quarterly earnings report 10-Q filing breaks them down鈥攁nd our AI translates the accounting language into plain English so you can focus on the numbers.
StockTitan delivers more than a link list. Our platform offers:
- AI-powered summaries that turn a RingCentral annual report 10-K simplified into a five-minute read
- Side-by-side metrics to speed up RingCentral earnings report filing analysis
- Instant explanations of any RingCentral 8-K material events explained so you see impact before the market reacts
Need governance details? The RingCentral proxy statement executive compensation section highlights pay packages, board composition, and share-based plans鈥攃ritical for assessing dilution. For new investors, understanding RingCentral SEC documents with AI answers common questions, making RingCentral SEC filings explained simply a reality.
Each filing lands here the moment EDGAR posts it, meaning you never miss material updates. Whether monitoring RingCentral executive stock transactions Form 4 before earnings or scanning a fresh S-8 for potential dilution, the insights you need are in one place鈥攁ugmented by concise AI commentary and always up to date.
MIRA Pharmaceuticals (Nasdaq: MIRA) filed Amendment No.1 to its Schedule 14A calling a virtual annual meeting on 11 Sep 2025. Holders of record on 21 Jul 2025 will vote on five items:
- Proposal 1 鈥� issue MIRA shares (>20% dilution) to acquire privately-held SKNY Pharmaceuticals via a reverse subsidiary merger.
- Proposal 2 鈥� elect five directors (four current, plus SKNY CEO Kelly Stackpole).
- Proposal 3 鈥� ratify Salberg & Co. as 2025 auditor.
- Proposal 4 鈥� expand the 2022 Omnibus Incentive Plan.
- Proposal 5 鈥� allow adjournment if votes are insufficient.
Merger terms: each SKNY share converts into MIRA stock at a 1:1 exchange ratio, reflecting valuations of $30.5 m (SKNY) and $30 m (MIRA). Post-closing, legacy MIRA and SKNY holders will each own roughly 50 % of the combined company; SKNY must contribute at least $5 m in cash or equivalents. MIRA will remain listed on Nasdaq (MIRA); the 22 Jul 2025 closing price was $1.75.
The combined pipeline would include Phase I oral ketamine analog Ketamir-2, pre-clinical cognitive candidate MIRA-55, and SKNY-1 for metabolic and addiction disorders. Neither company currently generates revenue, and extensive risk disclosures cite liquidity needs, early-stage development, competition and possible share dilution. The board unanimously recommends voting 鈥淔OR鈥� all proposals.
Kanzhun Limited (BZ) 鈥� Form 144 filing overview
The notice discloses a proposed sale of 1,984,500 American Depositary Shares (ADS), each ADS representing two Class A ordinary shares. The filer intends to execute the transaction through UBS Financial Services, 11 Madison Ave., New York on or about 30 June 2025. Based on the filing鈥檚 stated market price, the block is valued at approximately US$35.9 million.
The issuer reports 913,310,598 ordinary shares outstanding; the proposed sale therefore represents roughly 0.22 % of the ordinary share count (鈮�0.43 % of the ADS float, given the 2-for-1 ratio). The securities were originally acquired on 20 May 2014 as 鈥淔ounder Shares鈥� in exchange for services rendered.
Recent insider activity: the same beneficial owner, Techwolf Limited, previously sold 1,921,500 ADS on 1 April 2025 for gross proceeds of US$32.17 million. Adding the new notice, total planned/ completed disposals within three months reach 3.91 million ADS (鈮圲S$68 million).
Form 144 is a notice of intent; it does not guarantee execution, but it signals potential supply and possible insider sentiment. No new capital is issued, so there is no dilution; however, the sales could create an overhang and incremental selling pressure around the proposed date.
Kanzhun Limited (BZ) 鈥� Form 144 filing overview
The notice discloses a proposed sale of 1,984,500 American Depositary Shares (ADS), each ADS representing two Class A ordinary shares. The filer intends to execute the transaction through UBS Financial Services, 11 Madison Ave., New York on or about 30 June 2025. Based on the filing鈥檚 stated market price, the block is valued at approximately US$35.9 million.
The issuer reports 913,310,598 ordinary shares outstanding; the proposed sale therefore represents roughly 0.22 % of the ordinary share count (鈮�0.43 % of the ADS float, given the 2-for-1 ratio). The securities were originally acquired on 20 May 2014 as 鈥淔ounder Shares鈥� in exchange for services rendered.
Recent insider activity: the same beneficial owner, Techwolf Limited, previously sold 1,921,500 ADS on 1 April 2025 for gross proceeds of US$32.17 million. Adding the new notice, total planned/ completed disposals within three months reach 3.91 million ADS (鈮圲S$68 million).
Form 144 is a notice of intent; it does not guarantee execution, but it signals potential supply and possible insider sentiment. No new capital is issued, so there is no dilution; however, the sales could create an overhang and incremental selling pressure around the proposed date.
RingCentral (NYSE:RNG) filed a Form 144 notifying the SEC of a proposed disposition of 27,055 common shares by company officer Kira Makagon. The shares, to be sold through Merrill Lynch on the NYSE, have an aggregate market value of $748,611.85. The transaction is slated to begin on or about June 27 2025 under a Rule 10b5-1 trading plan adopted on March 14 2025.
RingCentral reports approximately 80.13 million shares outstanding, so the planned sale represents roughly 0.03 % of total shares. The filer certified that they hold no undisclosed material adverse information, and no other insider sales were reported in the past three months.
RingCentral, Inc. (RNG) 鈥� Form 144 notice: an unidentified insider intends to sell 7,776 common shares through Morgan Stanley Smith Barney on or after 27 June 2025. The proposed sale is valued at $215,161.92, versus 80,131,686 shares outstanding, representing less than 0.01% of current float. The shares originated from restricted stock units (RSUs) acquired 15 May 2025. No prior sales were reported during the past three months, and no additional material information or adverse corporate developments were disclosed in the filing.
FAQ
What is the current stock price of RingCentral (RNG)?
What is the market cap of RingCentral (RNG)?
What is RingCentral's core business?
How does RingCentral generate revenue?
What distinguishes RingCentral's cloud platform?
How does RingCentral eliminate the need for traditional phone systems?
What range of products and services does RingCentral offer?
How does RingCentral ensure operational reliability?
How does RingCentral integrate with other business applications?
